Results 51 to 60 of about 10,272,505 (150)

Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]

open access: yes, 2015
Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Nappi, Francesco   +13 more
core   +1 more source

Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro

open access: yesBiomolecules, 2018
High-carbohydrate containing diets have become a precursor to glucose-mediated protein glycation which has been linked to an increase in diabetic and cardiovascular complications.
Hardik Ghelani   +3 more
doaj   +1 more source

AGEs (Advanced Glycation End-products) in bone come of age

open access: yesBone
Advanced Glycation End-products (AGEs) are seen in long-lived proteins and were not expected to accumulate in the bone that turnovers and renews itself. Here, we provide a commentary on the contrary, highlighting the Special Issue of AGEs in Bone. An outcome of hyperglycemia and increased oxidative stress, AGEs form and accumulate by altering the bone ...
Vashishth, Deepak   +2 more
openaire   +3 more sources

Influence of food-derived advanced glycation end products on health [PDF]

open access: yes, 2018
Introduction. Advanced glycation end products (AGEs) are compounds formed endogenously in the human body. Besides this source of AGEs, they also exist in food and can be generated during cooking.
Galiniak, Sabina   +4 more
core   +2 more sources

Advanced glycation end-products and advanced oxidation protein products in schizophrenia

open access: yes, 2022
Schizophrenia pathophysiology is still not well understood. Genetic factors involving biochemical systems are key players and oxidative stress takes part to the development and worsening of SZ.
Pandolfo G.   +17 more
core   +1 more source

Consequences of the interaction of amyloid beta with amyloid binding alcohol dehydrogenase and the receptor for advanced glycation end products [PDF]

open access: yes, 2008
Amyloid beta (Aβ) has been postulated to be the principle initiator of the pathogenesis of Alzheimer’s disease (AD). Therefore, understanding the underlying mechanisms of Aβ induced neurotoxicity in the early stages of AD would be essential for finding ...
Ren, Yimin
core   +2 more sources

Lifestyle and advanced glycation end products (AGEs) burden: Its relevance to healthy aging [PDF]

open access: yes, 2014
Uncontrolled continued exposure to oxidative stress is a precursor to many chronic diseases including cancer, diabetes, degenerative disorders and cardiovascular diseases. Of the many known mediators of oxidative stress, reactive oxygen species (ROS) and
Marotta, Francesco   +4 more
core   +1 more source

Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin

open access: yesCells, 2019
Advanced glycation end products (AGEs) are the end products of the glycation reaction and have a great importance in clinical science for their association with oxidative stress and inflammation, which play a major role in most chronic diseases, such as ...
Margherita Borriello   +2 more
doaj   +1 more source

Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

open access: yesPLoS ONE, 2013
BackgroundNon-enzymatic glycation is the addition of free carbonyl group of reducing sugar to the free amino groups of proteins, resulting in the formation of a Schiff base and an Amadori product.
Saheem Ahmad   +7 more
doaj   +1 more source

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

open access: yes, 2010
The sRAGE [soluble RAGE (receptor for advanced glycation end-products)] lack the transmembrane and cytoplasmic domain of the full-length receptor and can function as a decoy for RAGE ligands.
D. John Betteridge   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy